CURRENT HEADLINES
- UniVessel SU: Sartorius Stedim Biotech Develops Next Generation Of Its Successful Single-Use Laboratory Bioreactor
- Therapure Biopharma Inc. Awarded US Government Contract For Development Of Anti-Nerve Gas Agent
- Patheon To Host Complimentary Seminar On 'Formulation, Funding And First-In-Man: A Stepwise Guide To Clinical Success'
- Event To Highlight 'Product Enhancement Through Complex Dosage Forms: Adding Value To Products’ Lifecycle Management'
- As The First Biopharmaceutical Company Worldwide, apceth Receives Approval For A Clinical Trial With Genetically Modified Adult Mesenchymal Stem Cells For The Treatment Of Cancer
SUPPLIER NEWS
- UniVessel SU: Sartorius Stedim Biotech Develops Next Generation Of Its Successful Single-Use Laboratory Bioreactor
- Finesse Solutions Launches TruBio DV 4.6 SCADA Software And SmartOPC Servers For Overlay On Applikon And Sartorius Bioreactor Controllers
- ATMI Opens Laboratory For Bioprocess Application Support At Bloomington, MN Site
- BioTek Instruments Announces Establishment Of Japanese Office
- Finesse Solutions Launches Next Generation G3Lab Universal SmartControllers To Enhance Productivity In Bench Scale Cell Culture And Fermentation
ARCHIVE NEWSLETTER
- 06.17.13 -- The Need For Flexible Facility Designs
- 06.12.13 -- Fundamentals Of Viral Clearance Studies: Study Design Factors For Optimal Log Reduction
- 06.10.13 -- Drive Improved Business Outcomes For Pharmacovigilance Organizations
- 06.05.13 -- Rapid Process Improvement to Culture Media Optimization
- 06.03.13 -- 5 Tips To Minimizing Risk In Your Cold Chain Packaging
BUSINESS WIRE PRESS
- Cubist Names Dr. Lorianne Masuoka Chief Medical Officer
- Mayo Clinic Forms Joint Venture With Cancer Genetics
- Liquidia Technologies Announces Extension Of Collaboration With PATH To Develop Next Generation Pneumococcal Vaccine
- Transgene Announces Its Invesment In ElsaLys Biotech, A New Antibody Company Created By Former Executives
- The Start-Up Elsalys Biotech, A New Player In The Therapeutic Monoclonal Antibody Arena, Announces The First Round Of Financing With Transgene And Sofimac Partners
- Otsuka's New Drug Application For Tolvaptan, The Investigational Compound For Autosomal Dominant Polycystic Kidney Disease (ADPKD), Accepted for Review By The US Food And Drug Administration (FDA)
DOWNLOAD LIBRARY
| | Download software |
DISCUSSION FORUMS
What's the industry buzz? Join a discussion forum to find out. Connect with your colleagues…ask questions, share information, discuss recent trends.
Join the discussion...
EVENTS CALENDAR
| | Search events |
| | Post events |
| | Stay informed |
Learn more...
ASSOCIATIONS
Looking for an industry association? Search our listings to find the association that fits your specialty.
Browse now...